AnX Robotica highlights 133-patient ARTIC study supporting ProScan AI performance
AnX Robotica reports 88.6% faster ProScan AI capsule reviews. Examine FDA evidence, diagnostic performance and why comparisons need caution.
AnX Robotica reports 88.6% faster ProScan AI capsule reviews. Examine FDA evidence, diagnostic performance and why comparisons need caution.
Humacyte’s ATEV beats AV fistula in Phase 3 dialysis access testing as peer-reviewed V007 data strengthen its planned 2026 FDA filing.